Cited by

• Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity.

  Baltazar P, de Melo Junior AF, Fonseca NM, Lança MB, Faria A, Sequeira CO, Teixeira-Santos L, Monteiro EC, Campos Pinheiro L, Calado J, Sousa C, Morello J, Pereira SA. Baltazar P, et al. Genes (Basel). 2023 Aug 29;14(9):1719. doi: 10.3390/genes14091719. Genes (Basel). 2023. PMID: 37761859 Free PMC article. Review.
• Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

  Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B. Hoyer-Kuhn H, et al. Clin J Am Soc Nephrol. 2014 Mar;9(3):468-77. doi: 10.2215/CJN.06820613. Epub 2014 Jan 2. Clin J Am Soc Nephrol. 2014. PMID: 24385516 Free PMC article. Clinical Trial.
• The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis.

  Yu H, Zhong H, Liu Y, Zhang G. Yu H, et al. Clin Kidney J. 2024 Nov 29;18(4):sfae383. doi: 10.1093/ckj/sfae383. eCollection 2025 Apr. Clin Kidney J. 2024. PMID: 40207102 Free PMC article. Review.
• Bone metabolism in oxalosis: a single-center study using new imaging techniques and biomarkers.

  Bacchetta J, Fargue S, Boutroy S, Basmaison O, Vilayphiou N, Plotton I, Guebre-Egziabher F, Dohin B, Kohler R, Cochat P. Bacchetta J, et al. Pediatr Nephrol. 2010 Jun;25(6):1081-9. doi: 10.1007/s00467-010-1453-x. Epub 2010 Mar 6. Pediatr Nephrol. 2010. PMID: 20213134 Clinical Trial.
• In Silico Modeling of Liver Metabolism in a Human Disease Reveals a Key Enzyme for Histidine and Histamine Homeostasis.

  Pagliarini R, Castello R, Napolitano F, Borzone R, Annunziata P, Mandrile G, De Marchi M, Brunetti-Pierri N, di Bernardo D. Pagliarini R, et al. Cell Rep. 2016 Jun 7;15(10):2292-2300. doi: 10.1016/j.celrep.2016.05.014. Epub 2016 May 26. Cell Rep. 2016. PMID: 27239044 Free PMC article.